Introduction:

COVID-19 is a disease with predominance of respiratory and other organ and system symptoms and unlike other viruses, it may present sequelae. The terms post-acute COVID and chronic COVID have been suggested for patients with symptoms or signs of illness of three weeks and three months, respectively, after the onset of acute COVID-19. In this context, interest arose in establishing a baseline and follow-up to identify sequelae in patients diagnosed with COVID-19.

Objectives:

To identify post COVID-19 sequelae in patients with medical discharge for this pathology.

Methods:

A prospective descriptive study was conducted between the second and fourth quarter of 2021 with a population of 330 patients diagnosed with COVID-19. Baseline was established at the beginning of the study, followed by follow-up and control consultation to identify post-COVID-19 sequelae and to perform control spirometry.

Results:

The frequency of COVID-19 was 29.78% (330 cases/1108 attended). 43.94% of positive cases were in the 40-59 years age group, 28.8% (95/330) referred as comorbidity: cardiovascular disease, diabetes mellitus II and bronchial asthma. Post COVID-19 sequelae predominated: respiratory (61%), musculoskeletal (43%) and neurological (20%), with dyspnea, dorsalgia and headache, respectively. The duration of sequelae ranged from 21 days to seven months, spirometry showed a mild restrictive pattern in patients aged 41 to 50 years, all female.

Conclusions:

It is important to identify post-COVID-19 sequelae for treatment and recover the integral health.

        · resumen en Español     · texto en Español | Inglés     · Español ( pdf ) | Inglés ( pdf )